Scholarlink

Importance <p>Radiation-induced oral mucositis (RIOM) is a prevalent complication arising from radiation therapy for tumors or combined radiotherapy, but the therapeutic options available remain limited. Understanding its underlying mechanisms is crucial for developing effective interventions.</p> Objectives <p>To investigate whether keratinocyte necroptosis contributes to RIOM pathogenesis and evaluate the effects of RIPK3/MLKL inhibition.</p> Methods <p>A mouse model of RIOM was established with varying irradiation doses. Tongue tissues were analyzed via histological staining, immunohistochemistry, and Western blot. In vitro, keratinocytes were irradiated and treated with RIPK3 or MLKL inhibitors. Subsequently, cell viability, necroptosis, and inflammatory cytokine expression were assessed using CCK-8, LDH release, Western blot, flow cytometry and RT-qPCR.</p> Results <p>In irradiated mouse tongues, p-RIPK3/RIPK3 and p-MLKL/MLKL ratios were significantly elevated (<i>P</i> &lt; 0.01), accompanied by heightened expression levels of IL-1β and IL-6. Similar findings were observed in keratinocytes, which, after 12&#xa0;Gy irradiation for 2.5 days, reduced cell viability (<i>P</i> &lt; 0.001), enhanced necroptotic marker expression (<i>P</i> &lt; 0.001), and increased inflammatory cytokine levels (<i>P</i> &lt; 0.001). Furthermore, treatment with RIPK3 inhibitor GSK’872 or MLKL inhibitor GW806742X significantly reduced irradiation-induced keratinocyte cell death (<i>P</i> &lt; 0.001), LDH release (<i>P</i> &lt; 0.001) and the expression of inflammatory cytokines (<i>P</i> &lt; 0.01).</p> Conclusions <p>This study provides evidence that RIPK3/MLKL-mediated necroptosis in keratinocytes contributes to the pathogenesis of RIOM. Inhibiting this pathway reduces cell death and inflammation, suggesting a promising therapeutic target for the treatment of RIOM.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Keratinocyte necroptosis promotes the progression of radiation-induced oral mucositis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月7日

查看全文
  • Manqiong Dai,
  • Xingzhu Dai,
  • Yuee Liang,
  • Xiaoyu Li,
  • Huacong Huang,
  • Wanghong Zhao

摘要

Importance

Radiation-induced oral mucositis (RIOM) is a prevalent complication arising from radiation therapy for tumors or combined radiotherapy, but the therapeutic options available remain limited. Understanding its underlying mechanisms is crucial for developing effective interventions.

Objectives

To investigate whether keratinocyte necroptosis contributes to RIOM pathogenesis and evaluate the effects of RIPK3/MLKL inhibition.

Methods

A mouse model of RIOM was established with varying irradiation doses. Tongue tissues were analyzed via histological staining, immunohistochemistry, and Western blot. In vitro, keratinocytes were irradiated and treated with RIPK3 or MLKL inhibitors. Subsequently, cell viability, necroptosis, and inflammatory cytokine expression were assessed using CCK-8, LDH release, Western blot, flow cytometry and RT-qPCR.

Results

In irradiated mouse tongues, p-RIPK3/RIPK3 and p-MLKL/MLKL ratios were significantly elevated (P < 0.01), accompanied by heightened expression levels of IL-1β and IL-6. Similar findings were observed in keratinocytes, which, after 12 Gy irradiation for 2.5 days, reduced cell viability (P < 0.001), enhanced necroptotic marker expression (P < 0.001), and increased inflammatory cytokine levels (P < 0.001). Furthermore, treatment with RIPK3 inhibitor GSK’872 or MLKL inhibitor GW806742X significantly reduced irradiation-induced keratinocyte cell death (P < 0.001), LDH release (P < 0.001) and the expression of inflammatory cytokines (P < 0.01).

Conclusions

This study provides evidence that RIPK3/MLKL-mediated necroptosis in keratinocytes contributes to the pathogenesis of RIOM. Inhibiting this pathway reduces cell death and inflammation, suggesting a promising therapeutic target for the treatment of RIOM.